Pill versions of GLP-1 drugs arrive in 2026, but analysts say Eli Lilly’s lead in obesity and diabetes treatment should hold ...

Weight loss can seem like it comes with a list of dos and don’ts, making it overwhelming. Cardio is a particularly hot topic ...

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...

Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...

The other experimental drug is bimagrumab, which is designed to help patients on weight loss medications from losing too much ...

Can a mentor/peer-led strategy surpass professionally led behavioral weight management sessions to help patients with obesity maintain weight loss? If the findings of a recently published study are ...

As the calendar turns, many people start thinking less about reinvention and more about momentum. A new year is a clean slate ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...

According to the study, orforglipron users maintained their weight loss levels more closely after previously taking a rival's ...

Oprah Winfrey recently raved about the benefits of these drugs in a candid interview, sharing how they changed her life and ...